| Literature DB >> 26280832 |
Sung-Pin Tseng1, Sheng-Fan Wang2, Cheng-Yu Kuo3, Jun-Wei Huang2, Wei-Chun Hung4, Guan-Ming Ke5, Po-Liang Lu6.
Abstract
To investigate the efficacy of fosfomycin against extended-spectrum β-lactamases (ESBL) producing Escherichia coli in Taiwan and the resistance mechanisms and characterization of human and pig isolates, we analyzed 145 ESBL-producing isolates collected from two hospitals (n = 123) and five farms (n = 22) in Taiwan from February to May, 2013. Antimicrobial susceptibilities were determined. Clonal relatedness was determined by PFGE and multi-locus sequence typing. ESBLs, ampC, and fosfomycin resistant genes were detected by PCR, and their flanking regions were determined by PCR mapping and sequencing. The fosfomycin resistant mechanisms, including modification of the antibiotic target (MurA), functionless transporters (GlpT and UhpT) and their regulating genes such as uhpA, cyaA, and ptsI, and antibiotic inactivation by enzymes (FosA and FosC), were examined. The size and replicon type of plasmids carrying fosfomycin resistant genes were analyzed. Our results revealed the susceptibility rates of fosfomycin were 94% for human ESBL-producing E. coli isolates and 77% for pig isolates. The PFGE analysis revealed 79 pulsotypes. No pulsotype was found existing in both human and pig isolates. Three pulsotypes were distributed among isolates from two hospitals. ISEcp1 carrying blaCTX-M-group 9 was the predominant transposable elements of the ESBL genes. Among the thirteen fosfomycin resistant isolates, functionless transporters were identified in 9 isolates. Three isolates contained novel amino acid substitutions (Asn67Ile, Phe151Ser and Trp164Ser, Val146Ala and His159Tyr, respectively) in MurA (the target of fosfomycin). Four isolates had fosfomycin modified enzyme (fosA3) in their plasmids. The fosA3 gene was harboured in an IncN-type plasmid (101 kbp) in the three pig isolates and an IncB/O-type plasmid (113 kbp) in the human isolate. In conclusion, we identified that 6% and 23% of the ESBL-producing E. coli from human and pigs were resistant to fosfomycin, respectively, in Taiwan. No clonal spread was found between human and pig isolates. Functionless transporters were the major cause of fosfomycin resistance, and the fosA3-transferring plasmid between isolates warrants further monitoring.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26280832 PMCID: PMC4539220 DOI: 10.1371/journal.pone.0135864
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1A dendrogram of pulsotype relationships developed via the unweighted pair group method using arithmetic averages (UPGMA) with BioNumerics software version 6.5 (Applied Maths).
Pulsotypes were assigned to the same clusters if they exhibited 80% similarity in the dendrogram. Three major clusters (XXIX, XXXIV, and XLIV) were found in two hospitals.
Antibiotic resistant genes of the ESBL-producing E. coli human and pig isolates.
| Antibiotic resistance genes | No. (%) of total isolates in KMU hospital (n = 95) | No. (%) of total isolates in PT hospital (n = 28) | Pig isolates from 5 farms (n = 22) |
|---|---|---|---|
|
| |||
| SHV | 8 (8) | 1 (3) | 0 (0) |
| TEM-1 | 24 (25) | 9 (32) | 12 (54) |
| CTX-M-group 1 | 18 (18) | 10 (35) | 6 (27) |
| CTX-M-group 2 | 0 (0) | 0 (0) | 0 (0) |
| CTX-M-group 9 | 36 (37) | 7 (25) | 14 (63) |
| DHA-1 | 3 (3) | 0 (0) | 0 (0) |
| CMY-2 | 21(22) | 9 (32) | 5 (22) |
| TEM-1+ CTX-M-group 1 | 8 (8) | 1 (4) | 1 (5) |
| TEM-1+ CTX-M-group 9 | 5 (5) | 4 (14) | 7 (32) |
| TEM-1+ CMY-2 | 5 (5) | 6 (21) | 2 (10) |
| TEM-1+ CTX-M-group 1+CMY-2 | 1 (1) | 0 (0) | 1 (5) |
| TEM-1+ CTX-M-group 9+CMY-2 | 2 (2) | 0 (0) | 1 (5) |
| TEM-1+ CTX-M-group 1+DHA-1 | 1 (1) | 0 (0) | 0 (0) |
| SHV+TEM-1+CMY-2 | 3 (3) | 0 (0) | 0 (0) |
|
| |||
|
| 0 (0) | 0 (0) | 0 (0) |
|
| 1 (1) | 0 (0) | 3 (13) |
|
| 0 (0) | 0 (0) | 0 (0) |
a: TEM-1 was determined by sequencing.
Characteristics of fosfomycin-resistant E. coli isolates and reference strains.
| Isolate No. | Source | Pulsotype | ESBL type |
| MIC FOS | Growth | Amino acid substitution | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| G6P(+) | G6P(-) | G3P | G6P | MurA | GlpT | UhpT | |||||
|
| 1 | 2 | + | + | None | None | None | ||||
|
| Pig farm | XVII | CTX-M-group 9 | 128 | 256 | + | - | None | None | None | |
|
| Pig farm | XXIV | CTX-M-group 9 |
| 512 | 1024 | - | + | None | None | Ser122Ile Trp151Cys Phe187Tyr |
|
| Pig farm | XXIV | CTX-M-group 9 |
| 256 | 512 | - | + | None | None | None |
|
| Pig farm | XXIV | CTX-M-group 9 |
| 256 | 1024 | - | + | Asn67Ile | None | Arg83Cys |
|
| Pig farm | XII | CTX-M-group 9 | 512 | 1024 | - | - | Phe151Ser Trp164Ser | Leu174Val | None | |
|
| KMUH | XXXIII | CMY-2 | 256 | 512 | - | - | Val146Ala His159Tyr | None | Val85Leu | |
|
| KMUH | XXX | CTX-M-group 9 +CMY-2 |
| 256 | 1024 | - | + | None | Arg209His | None |
|
| KMUH | XLIX | CTX-M-group 9 | 128 | 256 | + | - | None | Arg50Cys Ala156Val | Ser26Arg His50Pro Ile149Met | |
|
| KMUH | V | SHV+ CMY-2 | 128 | 256 | - | - | None | None | Cys109Trp | |
|
| KMUH | LXVI | CTX-M-group 9 + CMY-2 | 128 | 256 | - | - | None | Gly142Cys Phe176Ser | Val18Leu | |
|
| PTH | XXXIV | CTX-M-group 1 +CMY-2 | 128 | 256 | - | + | None | Arg50Cys Ala156Val Val149Met | Lys132Glu Val143Met Tyr165His | |
|
| PTH | XXIX | CTX-M-group 1 | 128 | 256 | + | - | None | None | Lys132Glu Ile149Met Tyr165His | |
|
| PTH | XLIX | CTX-M-group 9 | 128 | 256 | + | - | None | Arg50Cys Ala156Val | Trp44Cys Gly134Asp | |
Fig 2Representation of the sequences flanking fosA3.
Genes are shown as arrows with the direction of transcription indicated by the arrowheads.
Characterization of 4 fosA3-habouring isolates and their transformants.
| Strain | Sources | PFGE type | MLST | Plasmid | Resistant gene content | Environment of | Resistant profiles | ||
|---|---|---|---|---|---|---|---|---|---|
| replicon | sizes (kb) | parental | transformant | ||||||
|
| Pig feces (Farm A) | XXIV | 744 |
| 146, |
| Type A | AM, AMK, TC, LVX, CHL, FOS, CTX | AM, FOS, CTX |
|
| Pig feces (Farm A) | XXIV | 744 |
| 146, |
| Type B | AM, AMK, TC, LVX, CHL, FOS, CTX | AM, FOS, CTX |
|
| Pig feces (Farm C) | XXIV | 744 |
| 142, |
| Type A | AM, AMK, TC, LVX, CHL, FOS, CTX | AM, FOS, CTX |
|
| Urine (KMUH) | XXX | 2310 | IncI1, IncFIB IncFrepB | 184, |
| Type A | AM, AMK, TC, LVX, CHL, FOS, CTX | AM, FOS, CTX |
a. Antibiotic susceptibility test were included AM, AMK, TC, LVX, CHL, FOS, CTX, and MEM. AM = Ampicillin, AMK = Amikacin, TC = Tetracycline, LVX = levofloxacin, CHL = Chloramphenicol, FOS = Fosfomycin, CTX = cefotaxime and, MEM = Meropenem.
b. The transferring plasmid containing resistant gene was underlined.
c. Structure of Type A and B were described in Fig 2.
Fig 3PFGE analysis of fosA3-producing E. coli.
(A) S1-nuclease digested plasmid profiles separated by PFGE. (B) S1-nuclease digested plasmid profiles hybridized with a fosA3 probe. The arrows showed the location of fosA3 genes. (C) S1-nuclease digested plasmid profiles hybridized with a bla CTX-M-group 9 probe. The arrows showed the location of bla CTX-M-group 9 genes. Lane M, MidRange II PFG Marker; lane1, A10; lane 2, A11; lane 3, A12 and lane 4, K66.
Evaluation of fosfomycin susceptibility in overexpressing wild type and mutant MurA.
| Bacterial strain | Enzyme overexpressed | MIC (μg/ml) |
|---|---|---|
| DH5α | None | 0.25 |
| DH5α/ | MurA (wild-type) | 8 |
| DH5α/ | MurA (Asn67Ile) | 128 |
| DH5α/ | MurA (Phe151Ser and Trp164Ser) | 128 |
| DH5α/ | MurA (Val146Ala and His159Tyr) | 128 |
MIC, minimal inhibitory concentration.
a MICs were determined in the presence of 1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) to induce MurA expression.